Dexter Matrana, DO
Allergy & Immunology · New Orleans, LANPI 1164927539
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 93.3% of the total across 49 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 28.1% of the total. Reporting peaked in 2022 at $497 and has fallen 73.6% since, to $131 in 2025. That places this record below the midpoint for allergy & immunology clinicians in LA, where the typical reported total is $3,029.
Across 49 payments — averaging $30.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$416
- Sanofi$231
- Biocryst US Sales Co., LLC$145
- CSL Behring$120
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$109
- Sanofi-aventis U.S. LLC$99
- plus $361 from 7 others
What the payments were for
- Food & beverage$1,38193%
- Education$997%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $416 |
| Sanofi | 8 | $231 |
| Biocryst US Sales Co., LLC | 3 | $145 |
| CSL Behring | 4 | $120 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $109 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Grifols Shared Services North America, Inc. | 1 | $97 |
| GSK | 4 | $65 |
| Grifols USA, LLC | 3 | $62 |
| Regeneron Healthcare Solutions, Inc. | 3 | $60 |
| AstraZeneca(2 entities) | 3 | $45 |
| Amgen | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,480 in reported general payments places this provider in the 35th percentile of 62 allergy & immunology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 33 | $121,910 |
| Azelastine Hcl | 16 | $471 |
| Fluticasone Propionate | 16 | $194 |
| Amlodipine Besylate | 14 | $91 |
| Atorvastatin Calcium | 13 | $80 |
Paid to pharmacies, not to this prescriber.
Other allergy & immunology in New Orleans
- Reena MehtaNew Orleans$159K
- Kenneth ParisNew Orleans$150K
- Cheryl WilliamsNew Orleans$12K
- Luke WallNew Orleans$7K
- Stephen DerbesNew Orleans$2K
- Michelle Korah-SedgwickNew Orleans$2K
- Jamie LurieNew Orleans$2K
- William DavisNew Orleans$2K
- Elizabeth WisnerNew Orleans$2K
- Meaghan McMahonNew Orleans$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.